Biotechnology Stocks II: Compare Returns of S&P 500 to C4 Therapeutics, Inc. (CCCC)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
Compare Returns for S&P 500 and CCCC | ||
---|---|---|
S&P 500 | CCCC | |
Start Date | Dec-01-2020 | Nov-30-2020 |
Start Price | $2,800.75 | $34.20 |
End Date | Apr-11-2025 | Apr-17-2025 |
End Price | $5,363.36 | $1.25 |
Number Monthly Prices | 54 | 54 |
Min Date | Oct-01-2022 | Apr-17-2025 |
Min Price | $3,943.01 | $1.25 |
Max Date | Dec-01-2024 | Sep-30-2021 |
Max Price | $6,010.09 | $44.68 |
Total Return | 19.88% | -96.35% |
Annualized Return | 4.11% | -52.07% |
Current Value of $1,000 Purchase | $1,199 | $37 |
Number Returns | 1,431 | 1,431 |
Average Return | 8.07% | -38.28% |
Minimum Return | -25.54% | -97.20% |
Maximum Return | 52.42% | 636.91% |
Number Profitable Returns | 980 | 265 |
Percent Profitable Returns | 68.48% | 18.52% |
Number Unprofitable Returns | 451 | 1,166 |
Percent Unprofitable Returns | 31.52% | 81.48% |
Profitable to Unprofitable Returns Ratio | 2.17 | 0.23 |
CCCC Performance Table and Chart
CCCC Dollar-cost Average
CCCC Trendline Chart
CCCC Moving Average Chart
CCCC Stock Return Map - See Patterns of Gains and Losses
CCCC Stock Returns/Purchase Dates